Search details
1.
Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study.
Lancet Oncol
; 22(10): 1468-1482, 2021 10.
Article
in English
| MEDLINE | ID: mdl-34592180
2.
Highlights from ASCO-GI 2021 from EORTC Gastrointestinal tract cancer group.
Br J Cancer
; 125(7): 911-919, 2021 09.
Article
in English
| MEDLINE | ID: mdl-34426663
3.
A phase 1a/1b trial of CSF-1R inhibitor LY3022855 in combination with durvalumab or tremelimumab in patients with advanced solid tumors.
Invest New Drugs
; 39(5): 1284-1297, 2021 10.
Article
in English
| MEDLINE | ID: mdl-33852104
4.
Preoperative Chemoradiotherapy for Gastroesophageal Junction Adenocarcinoma Modified by PET/CT: Results of Virtual Planning Study.
Medicina (Kaunas)
; 57(12)2021 Dec 06.
Article
in English
| MEDLINE | ID: mdl-34946279
5.
Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness.
BMC Cancer
; 19(1): 687, 2019 Jul 15.
Article
in English
| MEDLINE | ID: mdl-31307428
6.
Targeting HER2 for localised oesophageal cancer.
Lancet Oncol
; 23(2): 188-190, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35038428
7.
Phase I study of orally administered S-1 in combination with epirubicin and oxaliplatin in patients with advanced solid tumors and chemotherapy-naïve advanced or metastatic esophagogastric cancer.
Gastric Cancer
; 20(2): 358-367, 2017 Mar.
Article
in English
| MEDLINE | ID: mdl-27255289
8.
Insights into next developments in advanced gastric cancer.
Curr Opin Oncol
; 28(4): 367-75, 2016 07.
Article
in English
| MEDLINE | ID: mdl-27092990
9.
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study.
Lancet Oncol
; 16(4): 395-405, 2015 Apr.
Article
in English
| MEDLINE | ID: mdl-25728526
10.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Lancet Oncol
; 16(5): 499-508, 2015 May.
Article
in English
| MEDLINE | ID: mdl-25877855
11.
Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis.
BMC Cancer
; 14: 323, 2014 May 07.
Article
in English
| MEDLINE | ID: mdl-24884897
12.
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4).
Eur J Cancer
; 204: 114062, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38678762
13.
[Vitamin D: Its physiology, pathophysiology and significance in etiopathogenesis of malignant diseases]. / Vitamin D - jeho fyziologie, patofyziologie a význam v etiopatogenezi nádorových onemocnení
Cas Lek Cesk
; 152(1): 20-30, 2013.
Article
in Cs
| MEDLINE | ID: mdl-23448673
14.
Early-Onset Cancer in the Gastrointestinal Tract Is on the Rise-Evidence and Implications.
Cancer Discov
; 13(3): 538-551, 2023 03 01.
Article
in English
| MEDLINE | ID: mdl-36757194
15.
Definition, diagnosis and treatment of oligometastatic oesophagogastric cancer: A Delphi consensus study in Europe.
Eur J Cancer
; 185: 28-39, 2023 05.
Article
in English
| MEDLINE | ID: mdl-36947929
16.
Recent progress and current challenges of immunotherapy in advanced/metastatic esophagogastric adenocarcinoma.
Eur J Cancer
; 176: 13-29, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36183651
17.
Highlights from the 2022 ASCO gastrointestinal cancer symposium: An overview by the EORTC gastrointestinal tract cancer group.
Clin Colorectal Cancer
; 21(3): 188-197, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35637095
18.
European-Australasian consensus on the management of advanced gastric and gastro-oesophageal junction cancer: current practice and new directions.
Ther Adv Med Oncol
; 14: 17588359221118874, 2022.
Article
in English
| MEDLINE | ID: mdl-36051471
19.
Definitions and treatment of oligometastatic oesophagogastric cancer according to multidisciplinary tumour boards in Europe.
Eur J Cancer
; 164: 18-29, 2022 03.
Article
in English
| MEDLINE | ID: mdl-35134666
20.
Neoadjuvant Chemotherapy of Triple-Negative Breast Cancer: Evaluation of Early Clinical Response, Pathological Complete Response Rates, and Addition of Platinum Salts Benefit Based on Real-World Evidence.
Cancers (Basel)
; 13(7)2021 Mar 30.
Article
in English
| MEDLINE | ID: mdl-33808149